Jenifer Cotter
Women's Health · Virginia Beach, VANPI 1750636270
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.7% of the total across 296 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 28 manufacturers reported payments, led by AbbVie at 29.1% of the total. Among women's health clinicians in VA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 296 payments — averaging $19.03 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$2K
- Novo Nordisk$765
- Lilly USA, LLC$636
- Pfizer$368
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$283
- Astellas Pharma US Inc$271
- plus $2K from 22 others
What the payments were for
- Food & beverage$5,615100%
- Education$170%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 105 | $1,641 |
| Novo Nordisk | 32 | $765 |
| Lilly USA, LLC | 21 | $636 |
| Pfizer | 17 | $368 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 19 | $283 |
| Astellas Pharma US Inc | 15 | $271 |
| Myovant Sciences Inc. | 7 | $217 |
| Exeltis, USA Inc. | 12 | $195 |
| Biohaven Pharmaceuticals, Inc. | 6 | $156 |
| Biohaven Pharmaceutical Holding Company Ltd. | 6 | $140 |
| Mayne Pharma Commercial LLC | 7 | $101 |
| Organon | 5 | $101 |
| Amgen | 6 | $101 |
| Radius Health, Inc. | 4 | $90 |
| Sumitomo Pharma America, Inc. | 4 | $85 |
| Scynexis, Inc. | 5 | $70 |
| Ardelyx, Inc. | 4 | $64 |
| Millicent US Inc | 3 | $63 |
| Therapeuticsmd, Inc. | 3 | $46 |
| Mycovia Pharmaceuticals, Inc. | 3 | $45 |
| Avion Pharmaceuticals | 3 | $42 |
| Bayer | 1 | $27 |
| Agile Therapeutics, Inc. | 2 | $26 |
| Currax Pharmaceuticals LLC | 2 | $26 |
| Merck | 1 | $22 |
| Lupin Inc. | 1 | $18 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $16 |
| Evofem Biosciences, Inc. | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$5,632 in reported general payments places this provider in the 95th percentile of 188 women's health providers in Virginia.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MounjaroTirzepatide | 68 | $75,797 |
| OzempicSemaglutide | 37 | $55,300 |
| MyrbetriqMirabegron | 15 | $9,481 |
| Estradiol | 44 | $3,293 |
| ValacyclovirValacyclovir Hcl | 25 | $1,585 |
| Bupropion XlBupropion Hcl | 33 | $1,302 |
| Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst | 23 | $430 |
| Ondansetron OdtOndansetron | 11 | $233 |
| Topiramate | 22 | $211 |
| Nystatin | 11 | $71 |
| Fluconazole | 16 | $54 |
| Ondansetron Hcl | 11 | $37 |
| Metformin Hcl | 20 | $35 |
| Metformin Hcl ErMetformin Hcl | 12 | $34 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Lilly USA, LLCMounjaro | $636 | $75,79768 claims |
| Novo NordiskOzempic | $765 | $55,30037 claims |
| Astellas Pharma US IncMyrbetriq | $271 | $9,48115 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 188 women's health providers in Virginia.
Other women's health in Virginia Beach
- Heather HallbergVirginia Beach$27K
- Whitney CottonVirginia Beach$14K
- Maria CrippenVirginia Beach$2K
- Kathleen BrownVirginia Beach$2K
- Ashley MoanVirginia Beach$1K
- Allie SilcoxVirginia Beach$949
- Christina McMillanVirginia Beach$848
- Heather PayneCharlottesville$28K
- Kara ParkerRichmond$10K
- Jessica JohnsonHampton$3K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.